Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study-Reference-Cited by-同舟云学术

Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study

Published:2023-09 Issue:9 Volume:24 Page:1002-1017
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Leal Ticiana,Kotecha Rupesh,Ramlau Rodryg,Zhang Li,Milanowski Janusz,Cobo Manuel,Roubec Jaromir,Petruzelka Lubos,Havel Libor,Kalmadi Sujith,Ward Jeffrey,Andric Zoran,Berghmans Thierry,Gerber David E,Kloecker Goetz,Panikkar Rajiv,Aerts Joachim,Delmonte Angelo,Pless Miklos,Greil Richard,Rolfo Christian,Akerley Wallace,Eaton Michael,Iqbal Mussawar,Langer Corey

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Hendriks;Ann Oncol,2023

2. Therapy for stage IV non-small-cell lung cancer without driver alterations: ASCO living guideline, version 2022.2;Owen;J Clin Oncol,2023

3. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality;Stupp;Eur J Cancer,2012

4. Effect of Tumor-Treating Fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial;Stupp;JAMA,2017

5. Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial;Ceresoli;Lancet Oncol,2019

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial;The Lancet Respiratory Medicine;2024-09

2. Deciphering Dormant Cells of Lung Adenocarcinoma: Prognostic Insights from O-glycosylation-Related Tumor Dormancy Genes Using Machine Learning;International Journal of Molecular Sciences;2024-08-31

3. New promises and challenges in the treatment of advanced non-small-cell lung cancer;The Lancet;2024-08

4. Technical note: Computational study on thermal management schemes for tumor‐treating fields therapy;Medical Physics;2024-07-18

5. Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011–2022;Journal of Neuro-Oncology;2024-06-29